Scientists from the University of Oslo (UiO), Akershus University Hospital (Ahus), and international partners have released a new expert opinion in Nature Aging. The article brings together more than 25 researchers from around the world, including clinicians and internationally recognised leaders in the biology of ageing and metabolism, particularly in the study of nicotinamide adenine dinucleotide (NAD⁺). Their collective perspective underscores the global effort to understand how this tiny molecule, NAD⁺, could be key to healthier ageing and protection against diseases such as Alzheimer’s and Parkinson’s.

Researchers at London Health Sciences Centre Research Institute (LHSCRI) and Western University’s Schulich School of Medicine & Dentistry have launched a clinical trial that is evaluating a new type of dialysis filter called Elisio HX™ that may significantly improve outcomes for people living with kidney failure across Canada. Unlike standard filters, the innovative design developed by Nipro is engineered to remove a broader range of toxins from the blood – a breakthrough that scientists believe could help patients live longer, healthier lives.

A novel class of light-sensitive nanoparticles may one day enable new approaches to medical imaging. They were developed by a research team at Martin Luther University Halle-Wittenberg (MLU). The particles absorb laser light and convert them into heat thereby changing their internal structure, similar to folded proteins. The research was published in the journal “Communications Chemistry”.

An estimated 33-50% of heart attack survivors may experience some form of psychological distress, including depression, anxiety, psychosocial stress or post-traumatic stress disorder (PTSD), which can affect physical recovery and long-term health. People with persistent psychological distress lasting up to 12 months after a heart attack are nearly 1.5 times more likely to have a future cardiac event.